TABLE 1

Patients with Interval SNs

Patient no.SexAge (y)MelanomaBreslowClarkLocationInterval SNOther SN 1Other SN 2Survival*
1M62ALM3.8IVR third finger1/1 cubital0/1 axillary13 DOD
2M52U, Na5.5VR hypothenar eminence0/1 humeral1/1 axillary43 ITM, DOD
3F56SSM0.5IIIL paravertebral0/2 scapular0/3 axillary69 NED
4M35SSM3.0IVR paravertebral0/1 dorsal1/1 axillary21 AXM, DOD
5F63N3.0IVL scapular0/1 scapular0/1 cervical66 NED
6M43U3.9IVR calf0/1 popliteal0/1 femoral0/2 inguinal57 NED
7M57SSM, Na0.8IVR scapular0/2 scapular0/5 axillary57 NED
8F26S1.3IIIL wrist0/1 humeral0/1 axillary52 NED
9M67N1.1IIIR dorsal0/1 scapular0/3 axillary48 NED
10F34N0.9IVL forearm0/1 cubital0/1 axillary48 NED
11F36SSM0.5IIIMiddle dorsal0/2 scapular R0/1 axillary R0/2 axillary L43 NED
12M44N1.5IVL dorsal0/1 dorsal L0/3 axillary36 NED
13M73SSM1.2IIIR dorsal0/1 scapular§0/1 axillary34 NED
14M67SSM1.1IVL lumbar0/2 lumbar0/1 inguinal0/3 axillary15 NED
15M0SSM0.95IIIL shoulder0/0 scapular9 NED
16F45SSM, Na1.7IVL lumbar0/1 intercostal0/4 inguinal8 NED
17F73SSM2.4IVL Achilles' tendon2/4 popliteal2/4 inguinal1 NED
18F75N4.1IVL forearm0/1 cephalic vein0/3 distal cephalic vein (ISN)1 NED
  • * Follow-up in months: DOD = died of disease; ITM = in-transit metastases; NED = no evidence of disease; AXM = axillary metastases.

  • With regression.

  • With ulceration.

  • § Only nonblue SN.

  • Lymphatic channel was identified only in hot dissected tissues, without any other lymph drainage area.

  • No classic SN.

  • ALM = acral-lentiginous; U = unclassified; N = nodular; SSM = superficial spreading melanoma; Na = on a nevi; S = spitzoid.

  • Data for Interval SN, Other SN 1, and Other SN 2 are number of metastatic SNs/number of detected SNs and location of these nodes.